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3*P NMR spectra of tumor-infiltrating lymphocytes (TILs) were found to be significantly different from those of normal peripheral ymphocytes. 
The greatest difference was in the phosphodiester (PDE) region, mainly in the glycerophosphocholine (GPC) signal. Short-term activation of peri- 
pheral ymphocytes with interleu~n-2 induced a small increase in ATP levels. In all l~ph~ytes the phosphomon~ter (PME) region is dominated 
by phosph~~anol~ine (PE), while there is an unusual absence of phosph~holin~ (PC). Perfusion of these cells with high concentrations of chol- 
ine caused only a minimal increase in PC, indicating that choline kinase is not the rate limiting step of lecithin synthesis in lymphocytes. 
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1. INTRODUCTION 
The development of adoptive immunotherapy has 
raised new hopes in the treatment of fatal diseases uch 
as malignant melanoma [l]. The basis of this approach 
involves the activation of tumor-infiltrating lym- 
phocytes (TILs) with a lymphokine, particularly inter- 
leukin-2 (IL-2). To date there is no information on the 
salient metabolic differences between normal, 
IL-2-activated lymphocytes (LAK), and TILs. 
zymatic control of the phospholipid pathways in lym- 
phocytes. The preliminary results obtained and 
presented here show that there are indeed significant 
differences in phospholipid metabolism between nor- 
mal peripheral l~phoc~es and TILs, as well as MRS 
detected changes in energy metabolism following lym- 
phokine activation. To our knowledge these are the first 
reported 31P MR spectra of TILs. 
The ‘rP NMR method is a valuable means to study 
the energy and phospholipid metabolism in intact viable 
cells, and can provide information on biochemical 
changes occurring during cell stimulation or inhibition 
[2]. The application of 3’P MRS in this study is an at- 
tempt to provide information on the metabolic status of 
the various kinds of lymphocytes, particularly their 
energy status (from the levels of ATP and Pi), and their 
phospholipid synthesis status (from their PME and 
PDE signals). Previously there have been a few at- 
tempts to study lymphocytes by these methods [3-51. 
Such studies are not only of intrinsic interest, but may 
also provide information on the processes that are oc- 
curring in vivo, and might lead to non-invasive detec- 
tion of changes using clinical in vivo MRS [5]. 
2. MATERIALS AND METHODS 
2.1. Lymphocyte preparation 
The purposes of this investigation were to define the 
“P MRS features of the various types of lymphocytes, 
to check whether there are significant MR spectral dif- 
ferences between them, to quantitate ATP levels of in- 
tact activated lymphocytes, and to investigate the en- 
Peripheral lymphocytes used in these studies were obtained from 
healthy volunteers through the NIH blood bank. The lymphocytes 
were collected through the apheresis technique, and separated and 
concentrated with the Ficoll-Paque method (Pharmacia LKB 
Biotechnology Inc.). For each NMR experiment 5 rf: 1 X 10’ lym- 
phocytes were used. For LAK cells, peripheral ymphocytes from pa- 
tients with malignant melanoma were similarly isolated and cultured 
for 3-4 days in AIM-V growth medium (GIBCO Lab.) with 10’ U/ml 
IL-2 (Human Recombinant Interleukin-2, Cetus Corporation) prior 
to the NMR measurements. The TILs which were studied here were 
from patients with metastatic malignant melanoma. Briefly, tumors 
were enzymatically dissected to single cell suspensions and placed into 
culture in AIM-V with IO3 U/ml IL-2 and 20% LAK eel1 supernatant 
[6]. At one week cells were centrifuged and resuspended in fresh AIM- 
V with IL-2 and supernatant. When exponential growth of lym- 
phocytes was observed at about 10 days TILs were maintained at den- 
sities between 5 x Id/ml and 2 x 106/ml by dilution into AIM-V with 
id U/ml IL-2. TILs were grown for 32-36 days prior to NMR 
studies. This was mostly due to the need to have a large number of 
lymphocytes for each experiment. Because of obvious clinical needs, 
the TILs used in these experiments were less than 5% of large TIL 
cultures used for patient treatments. Therefore, there were no NMR 
data of ‘young’ TILs. 
Correspondence address: 0. Kaplan, Medicine Branch, Division of 
Cancer Treatment, National Cancer Institute, NIH, Bethesda, MD 
2Og92, USA 
2.2. Preparations of lymphocytes for “P MRS 
Lymphocytes were harvested, centrifuged at 4’C at 1500 rpm for 10 
min and washed 3 times in growth medium. Two methods were used: 
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perfused lymphocytes and cell suspensions. Perfused lymphocytes 
were cast in agarose threads as follows [7]: cells were suspended in a 
low-gelling temperature agarose by mixing 0.6-0.8 ml of cells 
(5 f 1 x 10s) with 1.25 volumes of 3% agarose in phosphate-buffered 
saline at 37”C, and extruding the mixture through 0.5 mm internal 
diameter teflon tubing into a 10 mm NMR tube. The solid threads 
were concentrated without compression at the bottom of the NMR 
tube by using an insert with inlet and outlet tubing. The inflow tube 
(also 0.5 mm internal diameter) was placed near the bottom of the 
tube, and the outflow was directed into an opening in the insert. The 
perfusion solution consisted of Improved Minimal Eagle’s Medium 
(IMEM), because of the need to know and control the concentrations 
of the constituents (the components of AIM-V have not been publish- 
ed). A peristaltic pump (Pharmacia P-3) maintained a constant perfu- 
sion rate of 0.5 ml/min. All experiments were performed at the 
physiologic temperature of 37°C. In each series of experiments con- 
trol spectra were recorded prior to changing the perfusion solution. 
NMR studies of lymphocyte suspensions were done in order to in- 
vestigate IL-2 effects, since IL-2 was considered to be too large (MW 
18000) to penetrate the agarose threads. The lymphocytes were 
harvested and washed as described previously, and the pellet was 
transferred to a 10 mm NMR tube and diluted to a total volume of 2 
ml with growth medium. Oxygen was continuously bubbled at the 
bottom of the tube to oxygenate the lymphocytes and to prevent settl- 
ing. Each series of experiments with either perfused or suspended cells 
was repeated at least 3 times. 
“P spectra were recorded at 162 MHz on a Varian XL-400 NMR 
spectrometer. Each spectrum was collected for 400 or 800 scans 
(depending upon the amount of cells), using a 3 s repetition time, 35 
ms pulse width (60”) and 20 Hz line broadening. “P chemical shifts 
were determined by standardizing lycerophosphocholine (GPC) to 
0.49 ppm as an internal standard, and in some spectra where GPC was 
absent, by standardizing fl-ATP to - 18.7 ppm. For quantitative 
analysis peak integrals were measured, and MRS data acquisition and 
processing were performed with identical parameters throughout all 
experiments. After completion of the MRS the protein content of 
each sample was determined by the bicinchoninic acid assay (Pierce). 
This enabled standardization of the actual amount of lymphocytes us- 
ed in each experiment, and made quantitative comparisons feasible. 
3. RESULTS AND DISCUSSION 
Lymphocytes are non-anchorage dependent cells and 
the preliminary set of experiments was designed to find 
the optimal conditions of casting to prevent loss of lym- 
phocytes from the threads during perfusion. In our 
previous studies with human cancer cells [8], 1.8% 
agarose in equal volumes with the cells were used. 
However, because of the much smaller size of human 
lymphocytes, various agarose concentrations (1.8, 2.5, 
3.0, 3.5%) and volumes were studied by NMR 
measurements concomitant with collecting and coun- 
ting the lymphocytes that were washed out with the ef- 
fluent. It was found that the optimal conditions were 
3% agarose and 1.25: 1 ratio of agarose to cell volume. 
However, even under the best conditions there was still 
a wash-out of ca. l-2% of lymphocytes per hour, and 
therefore all experiments with threads were continued 
for only up to 12 h. 
The “P MR spectrum of non-activated peripheral 
lymphocytes is shown in fig.1. The assignment of the 
signals was according to previous published data on 
lymphocytes [3]. The phosphomonoester (PME) region 
is governed by the phosphoethanolamine (PE) peak at 
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Fig. 1. “P NMR spectra of normal lymphocytes, IL-2 activated lym- 
phocytes and tumor-infiltrating lymphocytes (for acquisition 
parameters ee section 2; LB = 20 Hz). 
4.4 + 0.1 ppm. Phosphocholine, a lecithin precursor, 
which is the dominant PME signal in most benign and 
malignant cells [8], is negligible in lymphocytes. Also 
typical to non-activated lymphocytes are the very low 
signals of the phosphodiester (PDE) degradation prod- 
ucts of phospholipids, i.e. glycerophosphocholine 
(GPC) and glycerophosphoethanolamine (GPE). There 
is no phosphocreatine in lymphocytes, and we have ob- 
tained higher ATP levels compared to previously 
published data [3-51. This finding of relatively high 
ATP concentrations, even in non-activated lym- 
phocytes, was very reproducible. This is probably due 
to the large number of lymphocytes which were used in 
each experiment which gave a good signal-to-noise 
ratio, and to our improved method of lymphocyte 
Volume 258, number 1 FEBS LETTERS November 1989 
casting and perfusion. We wish to emphasize the impor- 
tance of this point because another report tried to cor- 
relate ATP increase with IL-2 activation [5], but the in- 
itial low ATP levels may have resulted from 
methodological origins. It seems that a quantitative 
standardization method (for example, protein content 
determination) is essential for quantitative comparisons 
between different NMR measurements. 
Lymphocytes cultured with IL-2 for 3-4 days ex- 
hibited some NMR spectral changes (fig. l), namely in- 
creased GPC and GPE signals. As described above, 
IL-2 effects on energy metabolism were investigated in 
lymphocyte suspensions. The energetic status was deter- 
mined by the ATP/Pi ratio. Following the addition of 
IL-2 (16 units into the 2 ml in the tube) this ratio in- 
creased, but only by 20+ 12% after 5 h (fig.2). Since 
these experiments were performed in cell suspensions 
they were conducted for relatively short duration (up to 
5 h). Trypan blue staining at the end of the MRS studies 
showed that 90 + 5% of the lymphocytes were viable. In 
LAK cells that were incubated with IL-2 for 3-5 days 
ATP/Pi ratios are in the range of 1 lo-130% compared 
to non-activated lymphocytes. Thus it seems that IL-2 
induces a small early increase in the levels of high 
energy compounds in lymphocytes. Under the ex- 
perimental conditions of these studies only short tern 
IL-2 Effects 
time (mln) 
Fig.2. Changes in ratios of relative concentrations of ATP and in- 
organic phosphate following the addition of IL-2 into peripheral lym- 
phocyte suspensions. 
(hours) effects of IL-2 on lymphocytic energy 
metabolism could be investigated. Attempts are now 
underway to apply other techniques for prolonged 
(several days) lymphocyte perfusion in the NMR spec- 
trometer. 
TILs spectra were significantly different from spectra 
of peripheral and activated lymphocytes (fig.l), the 
main difference being a striking increase in GPC and 
GPE signals. These changes point to alterations in 
phospholipid metabolism, as GPC and GPE are the 
final phosphorous degradation products of phos- 
phatidylcholine (lecithin) and phosphatidylethanol- 
amine (cephalin), respectively [9]. These compounds 
are major constituents of membranes and the observed 
changes may reflect ‘maturation’ of the lymphocytes. 
However, it was previously postulated that GPC may 
also play a role in energy metabolism control, and act as 
a bioregulator of membranes [lo, 111. Thus, in- 
vestigating the remarkable increase of GPC in TILs 
may contribute to the understanding of the unique 
biological activity of these cells. In TILs as well as in the 
other lymphocyte types the PME region is governed by 
PE and there is almost no PC. There were no significant 
differences in ATP levels between TILs and LAK cells. 
The metabolic pathways of phospholipids were 
studied in perfused TILs. In previous studies from our 
C) 11-12 h 
b)4-5h 
Perfusion with choline (4 mM) 
-20 FFIJ 
Fig.3. “P NMR spectra of TILs perfused with IMEM containing 4 
mM choline (for acquisition parameters ee section 2; LB = 5 Hz). 
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Table 1 
The effects of 4 mM choline perfusion on the ratios of the NMR 
signals of TILs 
Control After 12 h 
PE/PC 
PE/GPE 
PC/GPC 
GPC/GPE 
2.81+ 0.24 2.17kO.21 
2.04Zto.19 1.43kO.12 
0.37*0.04 0.33 +0.05 
1.84kO.13 1.96kO.14 
laboratory, employing NMR techniques, it was found 
that in MDA-MB23 1 human breast cancer cells the rate- 
limiting enzyme of lecithin synthesis was cytidyl- 
transferase, and the rate was modulated by PC levels 
[12]. In TILs PC concentrations are very low, even 
though there is choline in AIM-V (concentrations were 
not released), and the reason cannot be substrate deple- 
tion. We have perfused TILs with IMEM containing 4 
mM choline (the physiologic concentration is 0.015 
mM, and in normal IMEM there is 0.4 mM). This high 
concentration was used because choline is positively 
charged, and high intracellular levels were essential. 
Choline is an inhibitor of ethanolamine kinase and 
DPE diesterase [13]. Following perfusion with 4 mM 
choline-IMEM a small peak of PC appeared in the 
PME region (fig.3), but did not progressively increase 
throughout the experiments. Concomitant changes 
were PE decrease, and GPC and GPE increase as can be 
seen in table 1. These findings may indicate that the 
rate-limiting enzyme of lecithin synthesis in lym- 
phocytes is different from that of other cells that were 
studied [9,12], since phosphocholine has not ac- 
cumulated but rather is immediately converted into 
cytidyldiphosphocholine. This novel hypothesis is now 
being tested by using inhibitors of the terminal enzyme, 
DPE diesterase, of the lecithin synthetic pathway in 
NMR studies of perfused lymphocytes. 
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